Mohsen Eledrisi, MD, FACP, FACE
Department of Internal Medicine
Hamad Medical Corporation
Doha, Qatar
Calcium disorders
Case 1
 A 55-year-old man follows for hypertension
 No complaints
 Valsartan/Amlodipine, Atorvastatin
 BP is controlled. Normal examination
 Serum cr, K normal, ALT normal
 Serum calcium 2.82 mmol (11.3 mg) [2.12-2.62 (8.5-10.5)]
 How to approach serum calcium?
Evaluation of high
serum calcium
 Repeat serum calcium
 Check PTH
 Adjust for low albumin per formula (some labs do)
Or do ionized calcium
 Biotin can falsely  PTH. So, stop for 2 days & retest
 Common causes:
– Primary hyperparathyroidism (commonest)
– Medications: vitamin D, calcium, HCTZ
– Malignancy, multiple myeloma
Evaluation of serum calcium
 Serum calcium binds to albumin
 Low albumin results in less bound calcium & falsely
low total serum calcium
 Adjustment should be done for low albumin
 Corrected calcium = (0.8 (Normal albumin - patient’s
☓
albumin) + patient’s serum Ca
 Some labs do the correction. There are calculators
 Or can measure ionized calcium (more expensive)
Causes of hypercalcemia
V
I
T
A
M
I
N
T
R
A
P
FHH:
Familial hypocalciuric
hypercalcemia
itamin intoxication (D, A)
mmobilization
hiazide, Teriparatide, Theophylline,
Tamoxifen, Lithium
ddison’s disease, Acromegaly
ilk-alkali syndrome ( supplemental Ca++)
nflammation/infection
(TB, sarcoidosis, fungal)
eoplasia (kidney, lung, breast, MM,
bone mets, lymphoma, leukemia..)
hyrotoxicosis
habdomyolsis (recovery stage)
IDS
arathyroidism (1ry
,3ry
)
Pheochromocytoma
Parenteral nutrition
Determining the cause of
high serum calcium
  (or high NL) PTH= 1ry
hyperparathyroidism
 No symptoms: usually 1ry
hyperparathyroidism
 Medications history
– Thiazides (HCTZ, chlorthalidone) & Lithium can  Ca++
, PTH
– Stop for 3 months then repeat labs
 If PTH is low normal or low, evaluate for non-PTH causes
 Severe high calcium with symptoms: think malignancy
Defining the severity
of hypercalcemia
 Mild:
 Serum calcium < 3 mmol (12 mg)
 Usually no symptoms
 Moderate:
 Serum calcium 3-3.49 mmol (12-14 mg)
 May have symptoms depending on level and rate of rise
 Severe:
 Serum calcium > 3.49 mmol (14 mg)
 Usually have severe symptoms
Manifestations of
hypercalcemia
 Depend on level of serum calcium & its progression
 Can be asymptomatic (usually with calcium <12 mg)
 Polyuria, polydipsia, anorexia, nausea, constipation
 Weakness, confusion, coma (with severe hypercalcemia)
Kidney involvement (causing AKI or/and CKD):
 Nephrolithiasis (kidney stones)
 Nephrocalcinosis (calcium deposition in kidneys)
Determining the cause of
high serum calcium
• PTHrp is high in hypercalcemia of malignancy (order if
the diagnosis is not clear)
• If no malignancy, look for other causes
• 1,25-(OH)2 vitamin D is high in granulomas (TB,
sarcoidosis), lymphoma
• 25-(OH) vitamin D is high with vitamin D intoxication
• If suspecting multiple myeloma, do SPEP & UPEP
Back to case 1
 A 55-year-old man follows for hypertension
 No complaints
 Valsartan/Amlodipine, Atorvastatin
 Serum cr, K normal, calcium 11.3 mg (normal: 8.5-10.5)
How to approach serum calcium?
Repeat calcium = 11.2 mg
PTH 75 (15-65 pg/mL)
What is your assessment?
www.uptodate.com
Primary hyperparathyroidism
 High serum calcium with high (or normal) PTH level
 Most often caused by a single parathyroid adenoma
 Evaluation:
 Serum creatinine, eGFR, phosphorus
 25-hydroxyvitamin D
 24-hour urine calcium & creatinine excretion
 DXA scan (lumbar spine, hip, distal 1/3 radius)
 Renal imaging (X-ray, ultrasound or CT scan) to
detect stones
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Indication for surgery in
primary hyperparathyroidism
 Option for all patients (symptomatic & asymptomatic)
 Surgery is recommended if any of the following:
– Serum calcium >1.0 mg (0.25 mmol) above upper limit of normal
– Osteoporosis (T score ≤ -2.5 on DXA) at any site
– Vertebral fracture (by radiograph, CT, MRI, or vertebral fracture assessment)
– eGFR <60 mL/min
– 24-hour urinary calcium [>250 mg/day (6.25 mmol/d) in women;
>300 mg/d (7.5 mmol/d) in men]
– Nephrolithiasis or nephrocalcinosis (by radiograph, ultrasound, or CT)
– Age < 50 years
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Imaging in primary
hyperparathyroidism
 Preoperative imaging is not recommended for
diagnostic purposes
 Preoperative imaging is recommended for those who
are going to have parathyroid surgery to locate the
abnormal parathyroid gland(s)
 Preoperative imaging modalities include high resolution
neck ultrasound, technetium-99 sestamibi scintigraphy,
and contrast-enhanced four-dimensional (4D)
computed tomography
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Follow up if no surgery
 Monitor the following:
• Serum calcium, 25-OH vitamin D every year
• Serum creatinine, eGFR every year
• DXA (3-site) every 1-2 years (as clinically indicated)
• Spine imaging if indicated (height loss or symptoms of
vertebral facture)
• Renal imaging (X-ray, U/S or CT), 24-hour urine calcium:
if clinically indicated (suspected kidney stones)
5th
International workshop. J Bone Miner Res 2022;37(11):2293
When to recommend surgery in
patients who are monitored?
 Serum calcium consistently >1.0 mg (0.25 mmol) above
the upper limit of normal
 A low trauma fracture
 A kidney stone
 A significant reduction in BMD to a T-score ≤ -2.5 at
any site
 A significant reduction in eGFR:
(>3 mL/min per year over 1-2 years)
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Medical management of
primary hyperparathyroidism:
general measures
 This can be offered for patients who refuse surgery or
when there is a contraindication for surgery
 Deficiencies in vitamin D and dietary calcium worsen
hyperparathyroidism
 Adequate calcium diet:
• 800 mg/ day for women <50 years and men <70 years
• 1000 mg/ day for women >50 years and men >70 years
 Adequate vitamin D intake:
• Serum 25-hydroxyvitamin D >30 ng (75 nmol)
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Medical management of
primary hyperparathyroidism:
drug therapy
1) Cinacalcet:
- Used if serum calcium > 1 mg (0.25 mmol) above the
upper limit of normal
- Decreases serum calcium
- Decreases PTH
2) Bisphosphonate (e.g. alendronate) or Denosumab:
- If low BMD
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Normocalcemic
primary hyperparathyroidism
 Normal total adjusted serum calcium, normal
ionized calcium and high PTH on at least 2 tests
over 3-6 months
 Rule out causes of secondary hyperparathyroidism
(vitamin D deficiency, CKD, celiac disease, bariatric surgery,
 calcium intake, malabsorption by pancreatic insufficiency )
 No adequate studies to guide management
 Some physicians use the same indications for surgery
in hypercalcemic primary hyperparathyroidism
 Many will obtain localization study before surgery
5th
International workshop. J Bone Miner Res 2022;37(11):2293
Familial hypocalciuric
hypercalcemia (FHH)
 A genetic condition due to mutations in the calcium-
sensing receptor gene leading to ↓ receptor activity
 Mildly high calcium with normal or mildly high PTH
 No symptoms, young (<30 y), family history of  Ca++
 Low urine Calcium:
- Calculate calcium-creatinine clearance (Ca/Cr Cl) ratio
[24-hour urine Ca x serum Cr] ÷ [serum Ca x 24-hour urine Cr]
♦ <0.01 with 24-hour urine <100 mg = highly likely FHH
Case 2
 A 65-year-old woman presents with nausea, vomiting
and confusion for 3 days
 Past history: DM, HTN
 Metformin, Lisinopril, Statin
 BP 110/66, pulse 112/min, normal temperature,
confused, systematic examination is normal
 Hb 9.2, creatinine 186 umol (2.1 mg), sodium 134,
potassium 4 mEq, calcium 3.24 mmol (13.0 mg)
 How would you approach?
Approach to severe
hypercalcemia
• Severe hypercalcemia:
– Severe symptoms
– Very high serum calcium [usually > 3.26 mmol (14 mg)]
– Commonly due to non-parathyroid cause
– Malignancy is the commonest
• Check PTH:
– High normal or high = primary hyperparathyroidism
– Low normal or low = Non-PTH causes
Determining the cause of
severe hypercalcemia
• Malignancy can be clear clinically
– Lung, breast, kidney, head & neck cancers, bone metastasis
– Multiple myeloma
• PTHrp is high in malignancy (order if diagnosis is not clear)
• If no malignancy, look for other causes
• 1,25-(OH)2 vitamin D is high in granulomas (TB, sarcoidosis), lympho
• 25-(OH) vitamin D is high with vitamin D intoxication
• If suspecting multiple myeloma, do SPEP & UPEP
Management of
severe hypercalcemia
1) IV Hydration:
 Patients are dehydrated
 IV normal saline
 Rate of IVF depends on patient’s age, presence of
cardiac or kidney disease
 If no evidence of edema, start 200 to 300 mL/hour
 Adjust rate to maintain urine output at 100-150 mL/hour
 Diuretics are not recommended
Management of
severe hypercalcemia
2) Calcitonin:
  Renal calcium excretion and  bone resorption
 IM or subcutaneous
 Nasal administration is not effective for hypercalcemia
 Starting dose: 4 units/kg every 8 hours
 For 24-48 hours
 No response after 48 hours (tachyphylaxis)
 Lowers serum calcium by 1 to 2 mg
Management of
severe hypercalcemia
3) Bisphosphonate:
 Usually the preferred agents
 Effect takes 2-4 days
 Given on presentation (with IVF and calcitonin)
 IV Zoledronic acid
 If not available, use Ibandronate or pamidronate (less effective)
4) Denosumab:
Use if severely low cr (eGFR<30) or if hypercalcemia
is not responsive to Bisphosphonate
Some centers use it as 1st
option
5) Dialysis
Management of
severe hypercalcemia
 Due to granulomatous disease (sarcoidosis,
TB), lymphoma)
–  1,25-dihydroxycholecalciferol (calcitriol) leads to 
intestinal calcium absorption
– Treatment: treat the underlying disease, glucocorticoids
– Glucocorticoids (as prednisone 20 to 40 mg/day)
Case 3
 A 45-year-old woman presents with muscle pain &
cramps, numbness over the hands for 3 months
 Thyroid surgery for “overactive thyroid” 6 months ago
Thyroxine 100 mcg qd
Normal BP, neck scar, thyroid is not palpable
 TSH 2.3, Serum cr, K normal, ALT normal
 Serum calcium 1.62 mmol (6.5 mg) [2.12-2.62 (8.5-10.5)]
 How would you approach serum calcium?
Approach to hypocalcemia
1) Repeat test
2) Check serum albumin
- Correct calcium if albumin is low
- Some labs do the correction. There are calculators
3) Can check ionized calcium, but expensive
4) Check PTH
5) Creatinine, phosphorus, magnesium, 25-OH vitamin D
Causes of hypocalcemia
 Post-surgical (thyroid, parathyroid surgery)
 Autoimmune hypoparathyroidism
– Can be isolated
– Or with chronic mucocutaneous candidiasis + adrenal
insufficiency (polyglandular syndrome type 1)
 Vitamin D deficiency
 Pseudohypoparathyroidism (PTH resistance)
 Acute or chronic kidney disease
 Acute pancreatitis
 Tumor lysis syndrome
 Hypomagnesemia, hyperphosphatemia
 Acute illness, burns, sepsis
Manifestations of hypocalcemia
 Perioral numbness
 Paresthesia of hands and feet
 Muscle cramps & pains
 Carpopedal spasm
 Laryngospasm
 Seizures (focal or generalized)
 Fatigue, irritability, anxiety, depression
 Some have no symptoms
Physical examination
• Trousseau's sign:
Induction of carpal spasm by inflation
of a sphygmomanometer above
systolic blood pressure for 3 minutes
• Chvostek's sign:
Contraction of the ipsilateral facial
muscles elicited by tapping the facial
nerve just anterior to the ear
(may occur in normal persons)
Evaluation of hypocalcemia
PTH Phosphorus Magnesium 25-OH vit D creatinine
Hypoparathyroidism   Normal Normal Normal
Pseudohypoparathyroidism   Normal Normal Normal
Hypomagnesemia Normal
or 
Normal  Normal Normal
Vitamin D deficiency   or normal Normal  Normal
Chronic kidney disease   Normal or  Normal 
Treatment of hypocalcemia
♦ Emergency management (IV calcium) if:
● Acute symptoms (carpopedal spasm, laryngospasm,
bronchospasm, seizures) or
● Serum calcium <1.75 mmol (7 mg)
 IV 1 gram calcium gluconate (10 ml, 10%) in 50 mL
5% dextrose or normal saline) over 10 minutes
 Can be repeated after 30-60 minutes
 Followed by IV infusion:
- 10 ampules of calcium gluconate in 1 liter D5 or NS
at rate of 50 ml/hour (can  to 100 ml/hour)
 Monitor serum calcium every 6 hours
 Treat underlying cause (hypoMg, vit D deficiency,…)
Treatment of hypocalcemia
♦ Further treatment:
 Start oral calcium
 Oral elemental calcium 1-2 grams/day
– Ca carbonate = 40% elemental calcium (1250 mg = 500 mg)
– Ca citrate = 21% elemental calcium
– Ca lactate = 13%
 If there is hypoparathyroidism:
 Vitamin D forms:
– Calcitriol 0.25 to 2 mcg /day (higher doses can be used)
– Or Alfacalcidiol 0.25 to 2 mcg/day (may need )
 Target calcium (in hypoparathyroidism):
- Low normal [2 to 2.12 mmol (8 to 8.5 mg)]
Easy Medicine ‫الزبدة‬
For talks & educational materials:
www.eledrisi.com
Needs VPN in Libya

More Related Content

PPTX
783762613-Hypercalcemia-and-Hyperparathyroidism.pptx
PPT
Hypercalcemia.ppt
PPTX
Managing hypercalcaemia presented on CMC, Kol, 1.10.2013
PPTX
Hypercalcemia
PPTX
Approach to Hypercalcemia
PPTX
HYPERCALCEMIA : :::: CALCIUM HOMEOSTASIS
PPTX
HYPERCALCEMIA AND HYPOCALCEMIA fina.pptx
PPTX
Parathyroid and calcium metabolism
783762613-Hypercalcemia-and-Hyperparathyroidism.pptx
Hypercalcemia.ppt
Managing hypercalcaemia presented on CMC, Kol, 1.10.2013
Hypercalcemia
Approach to Hypercalcemia
HYPERCALCEMIA : :::: CALCIUM HOMEOSTASIS
HYPERCALCEMIA AND HYPOCALCEMIA fina.pptx
Parathyroid and calcium metabolism

Similar to calcium_disorders-p.ppt................... (20)

PPTX
How to approach hypercalcaemia?
PPTX
hyper and hypocalcemia.pptx
PPTX
seminar ppt.pptxhikkjhhkllkkkkkllllllllllll
PPTX
Hypercalcemia atee
PPTX
Hypercalcemia ,causes and treatment
PPTX
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
PPTX
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
PPTX
Calcium metabolism and parathyroid disorders
PPT
Hypercalcemia
PPTX
Hypercalcemia, causes and treatment
PPTX
Approach to patient with hypo/hyper calcaemia
PDF
Hypercalcemia ppt.pdf
PPTX
Calcium metabolism handout
PDF
Calcium (1)............................................pdf
PPTX
parathyroid-Illuminata.pptx
PPTX
Approach to a patient with hypercalcaemia
PDF
hypercalcemia-171125132212.pdf
PPT
Hypercalcemia
PDF
hypercalcemia-171125132212.pdf
PPTX
Hypercalcemia and hypocalcemia dr bikal
How to approach hypercalcaemia?
hyper and hypocalcemia.pptx
seminar ppt.pptxhikkjhhkllkkkkkllllllllllll
Hypercalcemia atee
Hypercalcemia ,causes and treatment
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Hypercalcemia- Approach to the Diagnosis Palak Choksi.pptx
Calcium metabolism and parathyroid disorders
Hypercalcemia
Hypercalcemia, causes and treatment
Approach to patient with hypo/hyper calcaemia
Hypercalcemia ppt.pdf
Calcium metabolism handout
Calcium (1)............................................pdf
parathyroid-Illuminata.pptx
Approach to a patient with hypercalcaemia
hypercalcemia-171125132212.pdf
Hypercalcemia
hypercalcemia-171125132212.pdf
Hypercalcemia and hypocalcemia dr bikal
Ad

Recently uploaded (20)

PPTX
Manage HIV exposed child and a child with HIV infection.pptx
PPT
Rheumatology Member of Royal College of Physicians.ppt
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PDF
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPTX
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
PPTX
y4d nutrition and diet in pregnancy and postpartum
PDF
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PDF
OSCE Series Set 1 ( Questions & Answers ).pdf
PPTX
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
PDF
AGE(Acute Gastroenteritis)pdf. Specific.
PPTX
Post Op complications in general surgery
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PDF
focused on the development and application of glycoHILIC, pepHILIC, and comm...
PDF
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
PPTX
Effects of lipid metabolism 22 asfelagi.pptx
PPTX
preoerative assessment in anesthesia and critical care medicine
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Manage HIV exposed child and a child with HIV infection.pptx
Rheumatology Member of Royal College of Physicians.ppt
09. Diabetes in Pregnancy/ gestational.pptx
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
Acute Coronary Syndrome for Cardiology Conference
HYPERSENSITIVITY REACTIONS - Pathophysiology Notes for Second Year Pharm D St...
y4d nutrition and diet in pregnancy and postpartum
OSCE SERIES ( Questions & Answers ) - Set 3.pdf
Lecture 8- Cornea and Sclera .pdf 5tg year
OSCE Series Set 1 ( Questions & Answers ).pdf
Hearthhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh
AGE(Acute Gastroenteritis)pdf. Specific.
Post Op complications in general surgery
PEADIATRICS NOTES.docx lecture notes for medical students
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
focused on the development and application of glycoHILIC, pepHILIC, and comm...
04 dr. Rahajeng - dr.rahajeng-KOGI XIX 2025-ed1.pdf
Effects of lipid metabolism 22 asfelagi.pptx
preoerative assessment in anesthesia and critical care medicine
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Ad

calcium_disorders-p.ppt...................

  • 1. Mohsen Eledrisi, MD, FACP, FACE Department of Internal Medicine Hamad Medical Corporation Doha, Qatar Calcium disorders
  • 2. Case 1  A 55-year-old man follows for hypertension  No complaints  Valsartan/Amlodipine, Atorvastatin  BP is controlled. Normal examination  Serum cr, K normal, ALT normal  Serum calcium 2.82 mmol (11.3 mg) [2.12-2.62 (8.5-10.5)]  How to approach serum calcium?
  • 3. Evaluation of high serum calcium  Repeat serum calcium  Check PTH  Adjust for low albumin per formula (some labs do) Or do ionized calcium  Biotin can falsely  PTH. So, stop for 2 days & retest  Common causes: – Primary hyperparathyroidism (commonest) – Medications: vitamin D, calcium, HCTZ – Malignancy, multiple myeloma
  • 4. Evaluation of serum calcium  Serum calcium binds to albumin  Low albumin results in less bound calcium & falsely low total serum calcium  Adjustment should be done for low albumin  Corrected calcium = (0.8 (Normal albumin - patient’s ☓ albumin) + patient’s serum Ca  Some labs do the correction. There are calculators  Or can measure ionized calcium (more expensive)
  • 5. Causes of hypercalcemia V I T A M I N T R A P FHH: Familial hypocalciuric hypercalcemia itamin intoxication (D, A) mmobilization hiazide, Teriparatide, Theophylline, Tamoxifen, Lithium ddison’s disease, Acromegaly ilk-alkali syndrome ( supplemental Ca++) nflammation/infection (TB, sarcoidosis, fungal) eoplasia (kidney, lung, breast, MM, bone mets, lymphoma, leukemia..) hyrotoxicosis habdomyolsis (recovery stage) IDS arathyroidism (1ry ,3ry ) Pheochromocytoma Parenteral nutrition
  • 6. Determining the cause of high serum calcium   (or high NL) PTH= 1ry hyperparathyroidism  No symptoms: usually 1ry hyperparathyroidism  Medications history – Thiazides (HCTZ, chlorthalidone) & Lithium can  Ca++ , PTH – Stop for 3 months then repeat labs  If PTH is low normal or low, evaluate for non-PTH causes  Severe high calcium with symptoms: think malignancy
  • 7. Defining the severity of hypercalcemia  Mild:  Serum calcium < 3 mmol (12 mg)  Usually no symptoms  Moderate:  Serum calcium 3-3.49 mmol (12-14 mg)  May have symptoms depending on level and rate of rise  Severe:  Serum calcium > 3.49 mmol (14 mg)  Usually have severe symptoms
  • 8. Manifestations of hypercalcemia  Depend on level of serum calcium & its progression  Can be asymptomatic (usually with calcium <12 mg)  Polyuria, polydipsia, anorexia, nausea, constipation  Weakness, confusion, coma (with severe hypercalcemia) Kidney involvement (causing AKI or/and CKD):  Nephrolithiasis (kidney stones)  Nephrocalcinosis (calcium deposition in kidneys)
  • 9. Determining the cause of high serum calcium • PTHrp is high in hypercalcemia of malignancy (order if the diagnosis is not clear) • If no malignancy, look for other causes • 1,25-(OH)2 vitamin D is high in granulomas (TB, sarcoidosis), lymphoma • 25-(OH) vitamin D is high with vitamin D intoxication • If suspecting multiple myeloma, do SPEP & UPEP
  • 10. Back to case 1  A 55-year-old man follows for hypertension  No complaints  Valsartan/Amlodipine, Atorvastatin  Serum cr, K normal, calcium 11.3 mg (normal: 8.5-10.5) How to approach serum calcium? Repeat calcium = 11.2 mg PTH 75 (15-65 pg/mL) What is your assessment?
  • 12. Primary hyperparathyroidism  High serum calcium with high (or normal) PTH level  Most often caused by a single parathyroid adenoma  Evaluation:  Serum creatinine, eGFR, phosphorus  25-hydroxyvitamin D  24-hour urine calcium & creatinine excretion  DXA scan (lumbar spine, hip, distal 1/3 radius)  Renal imaging (X-ray, ultrasound or CT scan) to detect stones 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 13. Indication for surgery in primary hyperparathyroidism  Option for all patients (symptomatic & asymptomatic)  Surgery is recommended if any of the following: – Serum calcium >1.0 mg (0.25 mmol) above upper limit of normal – Osteoporosis (T score ≤ -2.5 on DXA) at any site – Vertebral fracture (by radiograph, CT, MRI, or vertebral fracture assessment) – eGFR <60 mL/min – 24-hour urinary calcium [>250 mg/day (6.25 mmol/d) in women; >300 mg/d (7.5 mmol/d) in men] – Nephrolithiasis or nephrocalcinosis (by radiograph, ultrasound, or CT) – Age < 50 years 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 14. Imaging in primary hyperparathyroidism  Preoperative imaging is not recommended for diagnostic purposes  Preoperative imaging is recommended for those who are going to have parathyroid surgery to locate the abnormal parathyroid gland(s)  Preoperative imaging modalities include high resolution neck ultrasound, technetium-99 sestamibi scintigraphy, and contrast-enhanced four-dimensional (4D) computed tomography 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 15. Follow up if no surgery  Monitor the following: • Serum calcium, 25-OH vitamin D every year • Serum creatinine, eGFR every year • DXA (3-site) every 1-2 years (as clinically indicated) • Spine imaging if indicated (height loss or symptoms of vertebral facture) • Renal imaging (X-ray, U/S or CT), 24-hour urine calcium: if clinically indicated (suspected kidney stones) 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 16. When to recommend surgery in patients who are monitored?  Serum calcium consistently >1.0 mg (0.25 mmol) above the upper limit of normal  A low trauma fracture  A kidney stone  A significant reduction in BMD to a T-score ≤ -2.5 at any site  A significant reduction in eGFR: (>3 mL/min per year over 1-2 years) 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 17. Medical management of primary hyperparathyroidism: general measures  This can be offered for patients who refuse surgery or when there is a contraindication for surgery  Deficiencies in vitamin D and dietary calcium worsen hyperparathyroidism  Adequate calcium diet: • 800 mg/ day for women <50 years and men <70 years • 1000 mg/ day for women >50 years and men >70 years  Adequate vitamin D intake: • Serum 25-hydroxyvitamin D >30 ng (75 nmol) 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 18. Medical management of primary hyperparathyroidism: drug therapy 1) Cinacalcet: - Used if serum calcium > 1 mg (0.25 mmol) above the upper limit of normal - Decreases serum calcium - Decreases PTH 2) Bisphosphonate (e.g. alendronate) or Denosumab: - If low BMD 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 19. Normocalcemic primary hyperparathyroidism  Normal total adjusted serum calcium, normal ionized calcium and high PTH on at least 2 tests over 3-6 months  Rule out causes of secondary hyperparathyroidism (vitamin D deficiency, CKD, celiac disease, bariatric surgery,  calcium intake, malabsorption by pancreatic insufficiency )  No adequate studies to guide management  Some physicians use the same indications for surgery in hypercalcemic primary hyperparathyroidism  Many will obtain localization study before surgery 5th International workshop. J Bone Miner Res 2022;37(11):2293
  • 20. Familial hypocalciuric hypercalcemia (FHH)  A genetic condition due to mutations in the calcium- sensing receptor gene leading to ↓ receptor activity  Mildly high calcium with normal or mildly high PTH  No symptoms, young (<30 y), family history of  Ca++  Low urine Calcium: - Calculate calcium-creatinine clearance (Ca/Cr Cl) ratio [24-hour urine Ca x serum Cr] ÷ [serum Ca x 24-hour urine Cr] ♦ <0.01 with 24-hour urine <100 mg = highly likely FHH
  • 21. Case 2  A 65-year-old woman presents with nausea, vomiting and confusion for 3 days  Past history: DM, HTN  Metformin, Lisinopril, Statin  BP 110/66, pulse 112/min, normal temperature, confused, systematic examination is normal  Hb 9.2, creatinine 186 umol (2.1 mg), sodium 134, potassium 4 mEq, calcium 3.24 mmol (13.0 mg)  How would you approach?
  • 22. Approach to severe hypercalcemia • Severe hypercalcemia: – Severe symptoms – Very high serum calcium [usually > 3.26 mmol (14 mg)] – Commonly due to non-parathyroid cause – Malignancy is the commonest • Check PTH: – High normal or high = primary hyperparathyroidism – Low normal or low = Non-PTH causes
  • 23. Determining the cause of severe hypercalcemia • Malignancy can be clear clinically – Lung, breast, kidney, head & neck cancers, bone metastasis – Multiple myeloma • PTHrp is high in malignancy (order if diagnosis is not clear) • If no malignancy, look for other causes • 1,25-(OH)2 vitamin D is high in granulomas (TB, sarcoidosis), lympho • 25-(OH) vitamin D is high with vitamin D intoxication • If suspecting multiple myeloma, do SPEP & UPEP
  • 24. Management of severe hypercalcemia 1) IV Hydration:  Patients are dehydrated  IV normal saline  Rate of IVF depends on patient’s age, presence of cardiac or kidney disease  If no evidence of edema, start 200 to 300 mL/hour  Adjust rate to maintain urine output at 100-150 mL/hour  Diuretics are not recommended
  • 25. Management of severe hypercalcemia 2) Calcitonin:   Renal calcium excretion and  bone resorption  IM or subcutaneous  Nasal administration is not effective for hypercalcemia  Starting dose: 4 units/kg every 8 hours  For 24-48 hours  No response after 48 hours (tachyphylaxis)  Lowers serum calcium by 1 to 2 mg
  • 26. Management of severe hypercalcemia 3) Bisphosphonate:  Usually the preferred agents  Effect takes 2-4 days  Given on presentation (with IVF and calcitonin)  IV Zoledronic acid  If not available, use Ibandronate or pamidronate (less effective) 4) Denosumab: Use if severely low cr (eGFR<30) or if hypercalcemia is not responsive to Bisphosphonate Some centers use it as 1st option 5) Dialysis
  • 27. Management of severe hypercalcemia  Due to granulomatous disease (sarcoidosis, TB), lymphoma) –  1,25-dihydroxycholecalciferol (calcitriol) leads to  intestinal calcium absorption – Treatment: treat the underlying disease, glucocorticoids – Glucocorticoids (as prednisone 20 to 40 mg/day)
  • 28. Case 3  A 45-year-old woman presents with muscle pain & cramps, numbness over the hands for 3 months  Thyroid surgery for “overactive thyroid” 6 months ago Thyroxine 100 mcg qd Normal BP, neck scar, thyroid is not palpable  TSH 2.3, Serum cr, K normal, ALT normal  Serum calcium 1.62 mmol (6.5 mg) [2.12-2.62 (8.5-10.5)]  How would you approach serum calcium?
  • 29. Approach to hypocalcemia 1) Repeat test 2) Check serum albumin - Correct calcium if albumin is low - Some labs do the correction. There are calculators 3) Can check ionized calcium, but expensive 4) Check PTH 5) Creatinine, phosphorus, magnesium, 25-OH vitamin D
  • 30. Causes of hypocalcemia  Post-surgical (thyroid, parathyroid surgery)  Autoimmune hypoparathyroidism – Can be isolated – Or with chronic mucocutaneous candidiasis + adrenal insufficiency (polyglandular syndrome type 1)  Vitamin D deficiency  Pseudohypoparathyroidism (PTH resistance)  Acute or chronic kidney disease  Acute pancreatitis  Tumor lysis syndrome  Hypomagnesemia, hyperphosphatemia  Acute illness, burns, sepsis
  • 31. Manifestations of hypocalcemia  Perioral numbness  Paresthesia of hands and feet  Muscle cramps & pains  Carpopedal spasm  Laryngospasm  Seizures (focal or generalized)  Fatigue, irritability, anxiety, depression  Some have no symptoms
  • 32. Physical examination • Trousseau's sign: Induction of carpal spasm by inflation of a sphygmomanometer above systolic blood pressure for 3 minutes • Chvostek's sign: Contraction of the ipsilateral facial muscles elicited by tapping the facial nerve just anterior to the ear (may occur in normal persons)
  • 33. Evaluation of hypocalcemia PTH Phosphorus Magnesium 25-OH vit D creatinine Hypoparathyroidism   Normal Normal Normal Pseudohypoparathyroidism   Normal Normal Normal Hypomagnesemia Normal or  Normal  Normal Normal Vitamin D deficiency   or normal Normal  Normal Chronic kidney disease   Normal or  Normal 
  • 34. Treatment of hypocalcemia ♦ Emergency management (IV calcium) if: ● Acute symptoms (carpopedal spasm, laryngospasm, bronchospasm, seizures) or ● Serum calcium <1.75 mmol (7 mg)  IV 1 gram calcium gluconate (10 ml, 10%) in 50 mL 5% dextrose or normal saline) over 10 minutes  Can be repeated after 30-60 minutes  Followed by IV infusion: - 10 ampules of calcium gluconate in 1 liter D5 or NS at rate of 50 ml/hour (can  to 100 ml/hour)  Monitor serum calcium every 6 hours  Treat underlying cause (hypoMg, vit D deficiency,…)
  • 35. Treatment of hypocalcemia ♦ Further treatment:  Start oral calcium  Oral elemental calcium 1-2 grams/day – Ca carbonate = 40% elemental calcium (1250 mg = 500 mg) – Ca citrate = 21% elemental calcium – Ca lactate = 13%  If there is hypoparathyroidism:  Vitamin D forms: – Calcitriol 0.25 to 2 mcg /day (higher doses can be used) – Or Alfacalcidiol 0.25 to 2 mcg/day (may need )  Target calcium (in hypoparathyroidism): - Low normal [2 to 2.12 mmol (8 to 8.5 mg)]
  • 36. Easy Medicine ‫الزبدة‬ For talks & educational materials: www.eledrisi.com Needs VPN in Libya